IDegLira Improves Glycemic Control in Japanese Patients with Uncontrolled Type 2 Diabetes on Premixed Insulin Therapy

INTRODUCTION: DUAL II Japan (NCT02911948) was a 26-week, phase 3a randomized, treat-to-target trial which compared the efficacy and safety of IDegLira with degludec in 210 Japanese patients with type 2 diabetes (T2D) uncontrolled on premixed or basal insulin therapy. The DUAL II Japan trial presente...

Descripción completa

Detalles Bibliográficos
Autores principales: Watada, Hirotaka, Ross Agner, Bue F., Doshi, Ankur, Bardtrum, Lars, Ranthe, Mattis Flyvholm, Billings, Liana K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965526/
https://www.ncbi.nlm.nih.gov/pubmed/31760599
http://dx.doi.org/10.1007/s13300-019-00730-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965526/
https://www.ncbi.nlm.nih.gov/pubmed/31760599
http://dx.doi.org/10.1007/s13300-019-00730-y

Ejemplares similares